Why the study?
Does brief, high-dose intravenous streptokinase infusion cause specific cardiac arrhythmias indicative of reperfusion in patients with acute myocardial infarction?
Does brief, high-dose intravenous streptokinase infusion cause specific cardiac arrhythmias indicative of reperfusion in patients with acute myocardial infarction?
Accelerated idioventricular rhythm during streptokinase infusion for acute myocardial infarction is a specific arrhythmia that can serve as a bedside clinical sign of successful reperfusion.
Answers are grounded in this paper and cite their sources.
Idioventricular rhythm may mark reperfusion during streptokinase therapy; hypothesis-generating and requires prospective validation before clinical use.
Cardiac arrhythmias are described during the first 2 h after brief, high-dose, intravenous streptokinase infusion in 23 patients with evolving myocardial infarction was given. A control group consisted of 22 similar patients with acute myocardial infarction not treated with streptokinase infusion. On the basis of an early peak of creatine kinase activity successful reperfusion was achieved in 60.9% of patients. Significantly more ventricular premature complexes (P less than 0.01) and paroxysms of idioventricular rhythm (P less than 0.05) were noticed in the treated group. Premature ventricular complexes did not predict any severe ventricular arrhythmia. Accelerated idioventricular rhythm appears to be the most specific arrhythmia encountered with thrombolytic therapy of acute myocardial infarction. We propose that in routine clinical work it can be used as a bedside sign of successful reperfusion.
No takes yet. Share an insight, caveat, or question.
Cercek et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: